Back

Uncovering the Genetic Architecture of Optic Nerve Integrity Estimates through Genome-wide Association Study Meta-analyses

Aman, A. M.; Diaz-Torres, S.; Lee, S. S.-Y.; Driessen, S. J.; de Vries, V. A.; van der Heide, F. C. T.; Kolovos, A.; Schmidt, J. M.; Marshall, H. N.; Saleh, L.; Schulze, A.; Blokland, G. A.; Webers, C. A. B.; van der Kallen, C. J. H.; Wesselius, A.; Arts, I.; van Asten, F.; Gorski, M.; Zimmermann, M. E.; Stark, K. J.; Heid, I. M.; Young, T. L.; Pasquale, L. R.; Segre, A. V.; Wiggs, J. L.; Khawaja, A. P.; Hewitt, A. W.; Schuster, A. K.; Berendschot, T. T. J. M.; Thiadens, A. A. H. J.; van Garderen, K. A.; Klaver, C. C. W.; Hysi, P. G.; Hammond, C. J.; Brandl, C.; Craig, J. E.; Ramdas, W. D.; Ma

2026-02-06 genetic and genomic medicine
10.64898/2026.02.03.26345426 medRxiv
Show abstract

We conducted the first genome-wide association meta-analyses of global and sectoral peripapillary retinal nerve fibre layer (pRNFL) thickness and Bruchs membrane opening-minimum rim width (BMO-MRW), the major optic nerve head structural and neurodegeneration biomarkers, including up to 25,942 and 12,080 participants, respectively, from the International Glaucoma Genetics Consortium. We identified 9 global pRNFL thickness and 9 global BMO-MRW loci, along with 28 and 19 loci for pRNFL and BMO-MRW sectors, respectively, comprising both shared and sector-specific loci. To identify intraocular pressure (IOP)-independent drug targets, global pRNFL thickness and BMO-MRW were conditioned on IOP. IOP-independent loci were then prioritised to identify candidate causal genes using transcriptome-wide association study and colocalization analysis. Several genes, such as NMNAT2 and TRIOBP, had robust associations with both phenotypes, with potential IOP-independent therapeutic translation for glaucoma. Overall, we identified novel loci for pRNFL thickness and BMO-MRW, highlighting potential drug-target genes acting independently from IOP, and elucidating genetic differences among pRNFL sectors.

Matching journals

The top 12 journals account for 50% of the predicted probability mass.

1
Nature Communications
4913 papers in training set
Top 13%
12.5%
2
eLife
5422 papers in training set
Top 13%
6.4%
3
Aging Cell
144 papers in training set
Top 1.0%
6.4%
4
Genome Medicine
154 papers in training set
Top 2%
3.6%
5
Communications Biology
886 papers in training set
Top 2%
3.6%
6
Scientific Reports
3102 papers in training set
Top 37%
3.6%
7
Journal of Clinical Investigation
164 papers in training set
Top 1%
3.6%
8
Cell Reports Medicine
140 papers in training set
Top 2%
2.7%
9
Cell Proliferation
12 papers in training set
Top 0.1%
2.7%
10
The American Journal of Human Genetics
206 papers in training set
Top 2%
2.4%
11
Brain
154 papers in training set
Top 2%
2.4%
12
Frontiers in Genetics
197 papers in training set
Top 3%
2.1%
50% of probability mass above
13
Cell Genomics
162 papers in training set
Top 2%
2.1%
14
JCI Insight
241 papers in training set
Top 3%
2.1%
15
Signal Transduction and Targeted Therapy
29 papers in training set
Top 0.6%
1.9%
16
Clinical and Translational Medicine
30 papers in training set
Top 0.2%
1.9%
17
Proceedings of the National Academy of Sciences
2130 papers in training set
Top 32%
1.7%
18
Developmental Cell
168 papers in training set
Top 8%
1.7%
19
Cell
370 papers in training set
Top 12%
1.5%
20
Med
38 papers in training set
Top 0.4%
1.3%
21
Science Advances
1098 papers in training set
Top 21%
1.3%
22
Advanced Science
249 papers in training set
Top 13%
1.3%
23
eBioMedicine
130 papers in training set
Top 2%
1.1%
24
Molecular Therapy
71 papers in training set
Top 2%
1.1%
25
PLOS ONE
4510 papers in training set
Top 62%
0.9%
26
Nature Human Behaviour
85 papers in training set
Top 3%
0.9%
27
Cell Death & Disease
126 papers in training set
Top 2%
0.9%
28
iScience
1063 papers in training set
Top 27%
0.9%
29
Nature Genetics
240 papers in training set
Top 6%
0.9%
30
Experimental & Molecular Medicine
14 papers in training set
Top 0.2%
0.8%